Jonathan H. Kaufman - Officer, Director, 10%+ Owner at Lipella Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Officer, Director, 10%+ Owner
Stock Symbol
LIPO on Nasdaq
All Insider Reports
All Insider Reports

Jonathan H. Kaufman - trading volume in the past year for Lipella Pharmaceuticals Inc.

Holdings reported by Jonathan H. Kaufman for Lipella Pharmaceuticals Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 899K $682K $0.76 May 14, 2024 Direct
Series C Voting Convertible Preferred Stock 303K Dec 31, 2024 By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) Common Stock
Stock Options 80K Mar 15, 2024 Direct Common Stock
Common Stock Purchase Warrants 11.8K Dec 31, 2024 By Self as proxy and power of attorney for Spartan Common Stock

Transactions reported by Jonathan H. Kaufman for Lipella Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.